SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001662252-18-000024
Filing Date
2018-02-06
Accepted
2018-02-06 15:40:18
Documents
1
Period of Report
2018-02-01
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K rcha8k.htm 8-K 21222
  Complete submission text file 0001662252-18-000024.txt   22344
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54767 | Film No.: 18577495
SIC: 2834 Pharmaceutical Preparations